Amir H. Daneshmanesh

Solna, AB 17164, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells.

ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells.

Journal: Biomedicines

Published: May 14, 2020

A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.

A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.

Journal: PloS one

Published: February 28, 2018

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells.

First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells.

Journal: Leukemia

Published: November 09, 2017

Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia.

Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: December 18, 2015

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.

Journal: PloS one

Published: July 01, 2015

The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies.

The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies.

Journal: British journal of haematology

Published: November 20, 2014

The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.

The receptor tyrosine kinase ROR1--an oncofetal antigen for targeted cancer therapy.

Journal: Seminars in cancer biology

Published: June 04, 2014

The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.

The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.

Journal: PloS one

Published: July 04, 2013

Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.

Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies.

Journal: Leukemia & lymphoma

Published: September 20, 2012

Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells.

Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells.

Journal: PloS one

Published: July 16, 2012

Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.

Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells.

Journal: Leukemia

Published: February 01, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026